We are live on ! Find out more
BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.47%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+15.47%
3 Year Est. Return
+121.5%
5 Year Est. Return
+265.65%
10 Year Est. Return
–
AUM
$3.62B
AUM Growth
+$67.3M
Cap. Flow
+$35.4M
Cap. Flow %
0.98%
Top 10 Hldgs %
68.09%
Holding
31
New
1
Increased
12
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$37.5M
2
ARGX icon
argenx
ARGX
+$30M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$26.1M
4
AKCA
Akcea Therapeutics Inc
AKCA
+$24.6M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$19.3M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$88M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$14.3M
3
CELG
Celgene Corp
CELG
+$9.6M
4
GILD icon
Gilead Sciences
GILD
+$7.95M
5
SAGE
Sage Therapeutics
SAGE
+$6.79M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVAX icon
26
Novavax
NVAX
$1.52B
$17.5M 0.48%
416,500
– –
FPRX
27
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$16.8M 0.46%
977,500
+150,000
+18% +$2.93M
PRTA icon
28
Prothena Corp
PRTA
$428M
$14.7M 0.41%
400,000
+50,000
+14% +$1.82M
CDTX
29
DELISTED
Cidara Therapeutics
CDTX
$9.18M 0.25%
114,764
– –
ACHN
30
DELISTED
Achillion Pharmaceuticals
ACHN
$4.75M 0.13%
1,279,340
– –
JUNO
31
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-1,925,000
Closed -$88M
1
2

Similar funds

SBAM
Santa Barbara Asset Management Los Angeles, California $6.43B AUM 10.99% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
SA
SQ Advisors Naples, Florida $1.32B AUM 10.3% 1-Year Est. Return
WF
WealthTrust Fairport Cleveland, Ohio $1.06B AUM 3.47% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return

BB Biotech's Q1 2018 Portfolio in Review

As of Q1 2018, BB Biotech held 31 positions worth $3.62B, up 1.9% from $3.55B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

BB Biotech's Q1 2018 filing shows 1 new, 12 increased, 6 reduced and 1 closed positions. Its largest new stake was argenx: 396,819 shares worth $31.9M. The largest sale was Juno Therapeutics, Inc., an estimated $88M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • BB Biotech's largest Q1 2018 buy was argenx: 396,819 shares worth $31.9M.
  • BB Biotech added most to TESARO, Inc. in Q1 2018, an estimated $37.5M increase.
  • BB Biotech's biggest Q1 2018 reduction was Agios Pharmaceuticals, cutting an estimated $14.3M.
  • BB Biotech fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $88M.
  • BB Biotech's ten largest holdings make up 68% of its $3.62B portfolio in Q1 2018.
  • BB Biotech opened 1 new position and closed 1 in Q1 2018.
  • BB Biotech's portfolio value rose 1.9% quarter-over-quarter to $3.62B.

Based on BB Biotech's 13F filing for Q1 2018, filed 8 May 2018.